These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. K-ras and p53 mutations in hamster pancreatic ductal adenocarcinomas and cell lines. Erill N; Cuatrecasas M; Sancho FJ; Farré A; Pour PM; Lluís F; Capellá G Am J Pathol; 1996 Oct; 149(4):1333-9. PubMed ID: 8863680 [TBL] [Abstract][Full Text] [Related]
4. p53 mutation without allelic loss and absence of mdm-2 amplification in a transplantable hamster pancreatic ductal adenocarcinoma and derived cell lines but not primary ductal adenocarcinomas in hamsters. Okita S; Tsutsumi M; Onji M; Konishi Y Mol Carcinog; 1995 Aug; 13(4):266-71. PubMed ID: 7646765 [TBL] [Abstract][Full Text] [Related]
5. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
6. K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cerny WL; Mangold KA; Scarpelli DG Cancer Res; 1992 Aug; 52(16):4507-13. PubMed ID: 1643642 [TBL] [Abstract][Full Text] [Related]
7. High yields of K-ras mutations in intraductal papillary mucinous tumors and invasive adenocarcinomas induced by N-nitroso(2-hydroxypropyl)(2-oxopropyl)amine in the pancreas of female Syrian hamsters. Sugio K; Gazdar AF; Albores-Saavedra J; Kokkinakis DM Carcinogenesis; 1996 Feb; 17(2):303-9. PubMed ID: 8625455 [TBL] [Abstract][Full Text] [Related]
8. Analysis of the K-ras and p53 pathways in X-ray-induced lung tumors in the rat. Belinsky SA; Middleton SK; Picksley SM; Hahn FF; Nikula KJ Radiat Res; 1996 Apr; 145(4):449-56. PubMed ID: 8600505 [TBL] [Abstract][Full Text] [Related]
9. Pancreatic ductal adenocarcinomas induced in Syrian hamsters by N-nitrosobis(2-oxopropyl)amine contain a c-Ki-ras oncogene with a point-mutated codon 12. Fujii H; Egami H; Chaney W; Pour P; Pelling J Mol Carcinog; 1990; 3(5):296-301. PubMed ID: 2173932 [TBL] [Abstract][Full Text] [Related]
10. p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas. Weyrer K; Feichtinger H; Haun M; Weiss G; Ofner D; Weger AR; Umlauft F; Grünewald K Lab Invest; 1996 Jan; 74(1):279-89. PubMed ID: 8569192 [TBL] [Abstract][Full Text] [Related]
12. Comparison of K-ras oncogene activation in pancreatic duct carcinomas and cholangiocarcinomas induced in hamsters by N-nitrosobis(2-hydroxypropyl)amine. Tsutsumi M; Murakami Y; Kondoh S; Tsujiuchi T; Hohnoki K; Horiguchi K; Noguchi O; Kobayashi E; Okita S; Sekiya T Jpn J Cancer Res; 1993 Sep; 84(9):956-60. PubMed ID: 8407562 [TBL] [Abstract][Full Text] [Related]
13. Ki-ras activation in pancreatic carcinomas of Syrian hamsters induced by N-nitrosobis(2-hydroxypropyl)amine. Ushijima T; Tsutsumi M; Sakai R; Ishizaka Y; Takaku F; Konishi Y; Takahashi M; Sugimura T; Nagao M Jpn J Cancer Res; 1991 Sep; 82(9):965-8. PubMed ID: 1657847 [TBL] [Abstract][Full Text] [Related]
14. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Pellegata NS; Sessa F; Renault B; Bonato M; Leone BE; Solcia E; Ranzani GN Cancer Res; 1994 Mar; 54(6):1556-60. PubMed ID: 8137263 [TBL] [Abstract][Full Text] [Related]
15. Activation of c-K-ras is frequent in pancreatic carcinomas of Syrian hamsters, but is absent in pancreatic tumors of rats. van Kranen HJ; Vermeulen E; Schoren L; Bax J; Woutersen RA; van Iersel P; van Kreijl CF; Scherer E Carcinogenesis; 1991 Aug; 12(8):1477-82. PubMed ID: 1860169 [TBL] [Abstract][Full Text] [Related]
16. Mutations of K-ras but not p53 genes in biliary duct and pancreatic duct carcinomas induced in hamsters by cholecystoduodenostomy with dissection of the common duct followed by N-nitrosobis(2-oxopropyl)amine. Majima T; Tsujiuchi T; Tsutsumi M; Tsunoda T; Konishi Y Cancer Lett; 1997 Sep; 118(1):47-53. PubMed ID: 9310259 [TBL] [Abstract][Full Text] [Related]
17. In vitro pancreatic ductal cell carcinogenesis. Ikematsu Y; Liu G; Fienhold MA; Cano M; Adrian TE; Hollingsworth MA; Williamson JE; Sanger W; Tomioka T; Pour PM Int J Cancer; 1997 Sep; 72(6):1095-103. PubMed ID: 9378545 [TBL] [Abstract][Full Text] [Related]
18. [Molecular pathways of pancreatic carcinogenesis]. Torrisani J; Buscail L Ann Pathol; 2002 Oct; 22(5):349-55. PubMed ID: 12483152 [TBL] [Abstract][Full Text] [Related]
19. In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Qian J; Niu J; Li M; Chiao PJ; Tsao MS Cancer Res; 2005 Jun; 65(12):5045-53. PubMed ID: 15958547 [TBL] [Abstract][Full Text] [Related]
20. K-ras gene mutation in early ductal lesions induced in a rapid production model for pancreatic carcinomas in Syrian hamsters. Tsutsumi M; Kondoh S; Noguchi O; Horiguchi K; Kobayashi E; Okita S; Ohashi K; Honoki K; Tsujiuchi T; Konishi Y Jpn J Cancer Res; 1993 Nov; 84(11):1101-5. PubMed ID: 8276713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]